AR and neoplasm: Although primary PCa is mostly an androgen-responsive tumor, the castration-resistant phenotype (CRPC) eventually emerges [28], and several mechanisms have been implicated, including heterogeneous loss of AR expression and aberrant promoter methylation [29].